ValiRx PLC (VAL)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

0.40p

Buy

0.42p

arrow-up0.00p (+0.00%)

Prices updated at 18 Dec 2025, 09:43 GMT

Prices minimum 15 mins delay

Prices in GBX

ValiRx PLC is a biopharmaceutical company. It is engaged in developing technologies and products in oncology therapeutics and diagnostics focused on the treatment of cancer and associated Biomarkers, specializing in epigenomic and genetic analysis.

FTSE All-Share

0.26%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2023	2024
	9,600	49,775
	8,160	49,775
	-2m	-2m
	-23,943.11	-4,302.70
	-2m	-2m
	-2m	-2m
Sales, General and administrative	2m	2m
Interest expenses	4,419	1,279
Provision for income taxes	-175,173	-127,696
Operating expenses	2m	2m
Income before taxes	-2m	-2m
Net income available to common shareholders	-2m	-2m
	-0.0201	-0.0145
Net interest income	-4,419	11,216
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	-0.0201	-0.0145
Free cash flow per share	-0.0277	-0.0136
Book value/share	0.0411	0.0103
Debt equity ratio	0.003684	0.000322

Balance sheet

Year chevron-l-regular chevron-r-regular	2023	2024
Current assets	566,477	2m
Current liabilities	214,654	345,023
Total capital	3m	4m
Total debt	22,070	11,862
Total equity	3m	4m
Total non current liabilities	-	-
Loans	11,857	1,390
Total assets	3m	4m
Total liabilities	-	-
Cash and cash equivalents	174,684	2m
Common stock	102m	374m

Cash flow

Year chevron-l-regular chevron-r-regular	2023	2024
Cash at beginning of period	1m	174,684
Cash dividends paid	-	-
	-2m	-2m
Investments (gains) losses	-306,181	-38,156
	174,684	2m
Net income	-	-
	-2m	-2m
	-306,181	-38,156

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.